Skip to main content
DAQING HUAKE CO.,LTD logo

DAQING HUAKE CO.,LTD — Investor Relations & Filings

Ticker · 000985 ISIN · CNE000001402 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,324 across all filing types
Latest filing 2025-01-20 Earnings Release
Country CN China
Listing Shenzhen Stock Exchange 000985

About DAQING HUAKE CO.,LTD

https://www.huake.com

Daqing Huake Co., Ltd. specializes in the deep processing of petrochemical products and the production of fine chemicals. The company's core business activities involve the research, development, manufacturing, and distribution of a diverse range of chemical materials. Key product lines include C5 and C9 petroleum resins, which are widely used in adhesives, coatings, and rubber compounding. Additionally, the company produces high-purity acetonitrile, isopropyl alcohol, and polypropylene. Daqing Huake leverages its proximity to major oil and gas resources to maintain a stable supply chain and focuses on technological innovation to enhance product quality. Its products serve various industrial sectors, including plastics, pharmaceuticals, and chemical synthesis, catering to both domestic and international markets.

Recent filings

Filing Released Lang Actions
大庆华科股份有限公司2024年度业绩预告
Earnings Release Classification · 95% confidence The document is titled '2024年度业绩预告' which translates to '2024 Annual Performance Forecast'. It provides estimated financial results for the full year 2024, including net profit and earnings per share projections. It explicitly states that the data is preliminary, unaudited, and subject to change in the final annual report. The document length is short (1442 characters) and it is a forward-looking earnings forecast rather than an actual financial report. This matches the characteristics of an Earnings Release (ER), which typically announces key financial highlights or forecasts before the full report is published. It is not a full Annual Report (10-K) or Interim Report (IR) because it lacks actual audited financial statements or detailed analysis. It is also not a Report Publication Announcement (RPA) because it contains substantive forecast data rather than just announcing a report's release.
2025-01-20 Chinese
大庆华科股份有限公司拟处置资产涉及的药业分公司相关资产市场价值资产评估报告（众华评报字【2024】第055号）
Regulatory Filings
2024-12-20 Chinese
大庆华科股份有限公司关于转让药业分公司部分资产的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's plan to transfer certain assets of its pharmaceutical subsidiary through a public listing on a property rights exchange. It details the transaction overview, board approval, asset evaluation, and the expected impact on the company. The document explicitly states that the transaction does not constitute a major asset restructuring under relevant regulations and that the transaction counterparties are not yet determined. The document is a disclosure of a capital asset transfer transaction and does not contain financial statements or detailed financial results. It is not a full financial report, earnings release, or management discussion. It is also not a report publication announcement since it contains substantive transaction details rather than just announcing a report's availability. The document fits best under the category of Capital/Financing Update (CAP), as it provides updates on company asset disposal and capital structure changes through asset transfer.
2024-12-20 Chinese
大庆华科股份有限公司拟处置资产涉及的药业分公司相关资产市场价值资产评估说明（众华评报字【2024】第055号）
Audit Report / Information Classification · 95% confidence The document is a detailed asset valuation report prepared by an asset appraisal company for Daqing Huake Co., Ltd. It includes extensive descriptions of the assets being evaluated, such as buildings, equipment, land use rights, and the methodologies used for valuation (cost method, market comparison, etc.). The document is technical and focused on asset appraisal for disposal purposes, with no indication of financial statements, earnings data, management commentary, or regulatory certifications. It is not an announcement or a brief summary but a full appraisal report. This fits the category of an Audit Report / Information (AR), which includes standalone audit or valuation reports and applied accounting principles related to asset valuation, excluding full annual or interim reports. Therefore, the appropriate classification is AR with high confidence.
2024-12-20 Chinese
大庆华科股份有限公司拟处置资产涉及的药业分公司相关资产市场价值资产评估报告（众华评报字【2024】第053号）
Audit Report / Information Classification · 95% confidence The document is an asset valuation report prepared by an asset evaluation company for Daqing Huake Co., Ltd. It details the market value assessment of assets related to a pharmaceutical subsidiary, including the evaluation purpose, methods, legal and regulatory basis, and detailed valuation results. The document is titled as an "资产评估报告" (Asset Evaluation Report) and includes comprehensive valuation data, assumptions, and conclusions. It is not an announcement or a brief summary but a full report containing substantive financial and asset valuation information. This fits the category of an Audit Report / Information (AR), as it is a standalone asset valuation report prepared according to regulatory standards and asset evaluation principles, distinct from a full Annual Report or other financial filings.
2024-12-20 Chinese
大庆华科股份有限公司第九届董事会2024年第二次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the company's board of directors meeting, including details about the meeting date, attendance, and voting results. It references a related asset transfer announcement published elsewhere. The content focuses on board decisions and meeting formalities, not on financial results or reports. Therefore, it fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board.
2024-12-20 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.